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a b s t r a c t 
Objectives: The mobile tigecycline resistance gene tet (X4), conferring resistance to all tetracyclines, is 
largely reported from China, however the global spread of such a novel resistance mechanism is a concern 
for preserving the efficacy of these last-resort antibiotics. The aim of our study was to determine the 
genetic basis of resistance in a tigecycline-resistant Escherichia coli strain (2-326) isolated from sewage in 
Bergen, Norway, using whole-genome sequencing (WGS). 
Methods: WGS was carried out using Illumina MiSeq-based sequencing. In vitro conjugation assays were 
performed to determine the potential of isolate 2-326 to transfer tigecycline resistance to other strains. 
Results: Escherichia coli isolate 2-326 belongs to pathogenic sequence type 167 (ST167) and carries several 
clinically important antibiotic resistance genes including tet (X4), bla CTX-M-14 , dfrA12, sul2, qnrS1 as well 
as several aminoglycoside resistance genes. Tigecycline resistance along with resistance to tetracycline, 
sulfamethoxazole, chloramphenicol and azithromycin was transferred to green fluorescent protein (GFP)- 
encoding E. coli strain CV601-GFP by conjugation. 
Conclusion: To the best of our knowledge, this is the first report of E. coli carrying mobile tet (X4) gene 
from Norway. Our study demonstrates the ongoing spread of new mechanisms of resistance against last- 
resort antibiotics and the need for surveillance of such resistance factors in the population in order to 
mitigate their spread. 
© 2021 Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 
This is an open access article under the CC BY-NC-ND license 


































Tigecycline is one of the last-resort antibiotics used to treat 
nfections caused by multidrug-resistant pathogens [1] . Recently, 
lasmid-mediated mobile tigecycline resistance gene tet (X4), con- 
erring resistance to all tetracyclines, was discovered in Escherichia 
oli isolates from China [2] . Although tet (X4) is largely reported 
rom China, the global spread of such a novel resistance mecha- 
ism is a concern for preserving the efficacy of these last-resort 
ntibiotics [3] . Here we report a multidrug-resistant E. coli isolate 
arrying tet (X4) from Norway for the first time. 
We obtained 685 E. coli isolates from influent and effluent sam- 
les collected from wastewater treatment plants in Bergen, Nor- 
ay, using ECC (CHROMagar, Paris, France) chromogenic media. 
ll of the isolates were checked for antimicrobial susceptibility 
data not shown) using EUVSEC Sensititre® plates (Thermo Fisher 
cientific, Germany) and were identified by matrix-assisted laser 
esorption/ionisation time-of-flight mass spectrometry (MALDI- ∗ Corresponding author. Tel. + 47 90 73 94 76; fax: + 47 55 23 85 31. 
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icense ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) OF/MS). One of the E. coli isolates (isolate 2-326) was resis- 
ant to tigecycline and nine other tested antibiotics ( Table 1 ). We 
pplied Illumina MiSeq-based sequencing for whole-genome se- 
uence (WGS) analysis of isolate 2-326, in order to understand the 
enetic basis of resistance. WGS data was assembled using SPAdes 
.3.13.0 [4] with default parameters as previously described [5] . 
enome annotation was performed using the National Center for 
iotechnology Information (NCBI) Prokaryotic Genome Annotation 
ipeline (PGAP) [6] . The draft genome of isolate 2-326 (GenBank 
ccession no. JADEZU0 0 0 0 0 0 0 0 0 ) has a size of 5 185 374 bp with 
 total of 135 contigs ( > 500 bp), an N 50 value of 131 135, 60X cov-
rage and a G + C content of 50.6%. 
Multilocus sequence typing (MLST) analysis ( https://pubmlst. 
rg/bigsdb?db=pubmlst _ ecoli _ achtman _ seqdef ) showed that isolate 
-326 belongs to sequence type 167 (ST167), which represents 
n epidemic clone of significant public-health concern that usu- 
lly encodes β-lactamases [7] . ResFinder 4.1 ( https://cge.cbs.dtu. 
k/services/ResFinder ) showed presence of several acquired an- 
imicrobial resistance genes in the genome of isolate 2-326, in- 
luding tet (X4) and extended-spectrum β-lactamase (ESBL) gene 
la ( Table 1 ) [8] . Isolate 2-326 also carried mutations in CTX-M-14 
robial Chemotherapy. This is an open access article under the CC BY-NC-ND 
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Fig. 1. Alignment of contigs from the draft genome sequence of isolate 2-326 with the reference plasmids: (A) IncFIA/FIB plasmid pG3X16-2-3 (accession no. NZ_CP038140.1 ) 
of 138.9 kb described in E. coli isolated from swine faeces in China in 2017; (B) IncFII plasmid pTHO-003-1 (accession no. AP022526.1 ) of 123.4 kb described in E. coli 
isolated from human sputum in Japan in 2018; (C) IncI1-I(Gamma) plasmid pST35-95663.1B (accession no. NZ_CP051282 ) of 95.8 kb described in Salmonella enterica serovar 
Typhimurium isolated from a bird in Canada in 2020; and (D) IncX4 plasmid pMNCRE44_4 (accession no. CP010880.1 ) of 30.8 kb described in E. coli isolated from human 
sepsis in the USA in 2012. Blue rings in each alignment represent the reference plasmid and the red ring represents contigs from the draft genome sequence of isolate 2-326 




























described in an E. coli strain isolated from swine faeces in China. yrA (D87N and S83L) and parC (S80I), thus explaining the high 
evel of ciprofloxacin resistance. Although several aminoglycoside 
esistance genes were detected in isolate 2-326 ( Table 1 ), no phe- 
otypic resistance to gentamicin was observed. This might be at- 
ributed to the fact that most of the aminoglycoside-modifying en- 
ymes detected in isolate 2-326 efficiently modify other aminogly- 
osides but not gentamicin [9] . 
VFanalyzer at the Virulence Factor Database [10] ( http://www. 
gc.ac.cn/cgi-bin/VFs/v5/main.cgi?func=VFanalyzer ) showed that 
solate 2-326 carried several virulence factors (Supplementary Ta- 
le S1), including yersiniabactin ( ybt ), sitABC , cytolysin A and type 
I secretion system, suggesting the potential for pathogenicity of 
his isolate. 
PlasmidFinder 2.1 ( https://cge.cbs.dtu.dk/services/Plasmid 
inder/ ) showed the presence of several plasmid repli- 38 ons such as IncFIA, IncFIB, IncFII, IncI1-I(Gamma) and 
ncX4 in isolate 2-326 [11] . We performed nucleotide BLAST 
 https://blast.ncbi.nlm.nih.gov/Blast.cgi ) using the contigs contain- 
ng antimicrobial resistance genes and plasmid replicons from 
he genome of isolate 2-326 against NCBI nucleotide collection 
atabase (nr/nt), in order to identify putative plasmids present 
n our isolate. We further aligned plasmids with the highest 
ucleotide identity from BLAST analysis to the draft genome 
equence of isolate 2-326 using CGView [12] . We identified pu- 
ative presence of four different previously reported plasmids 
n isolate 2-326 ( Fig. 1 ). The genome sequence of isolate 2-326 
ndicated putative presence of IncF1A/F1B plasmid pG3X16-2-3 
accession no. NZ_CP038140.1 ) with > 70% sequence coverage and 
ucleotide identity of > 99%. This plasmid carrying tet (X4) was first 
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Table 1 
Minimum inhibitory concentrations (MICs) of different antimicrobial agents tested against Escherichia coli isolate 2-326, the 
transconjugant (TC) of gfp E. coli and the recipient strain gfp E. coli , as well as antimicrobial resistance genes (ARGs) detected 
in the draft genome sequence of E. coli isolate 2-326 
Antimicrobial 
agent 
MIC of isolate 
2-326 ( μg/mL) 
ARGs detected in 
isolate 2-326 
MIC of TC- gfp 
E. coli a ( μg/mL) 
MIC of gfp 
E. coli a ( μg/mL) 
Ampicillin > 64 bla CTX-M-14 4 4 
Azithromycin > 64 erm(B), erm(42) > 64 8 
Cefotaxime > 4 bla CTX-M-14 < 0.25 < 0.25 
Ceftazidime 1 bla CTX-M-14 < 0.5 < 0.5 
Meropenem < 0.03 – < 0.03 < 0.03 
Nalidixic acid > 128 qnrS1 8 8 
Ciprofloxacin > 8 qnrS1 0.03 0.03 
Trimethoprim > 32 dfrA12 < 0.25 < 0.25 
Sulfamethoxazole > 1024 sul2 > 1024 < 8 
Tetracycline 64 tet (X4), tet (M) 64 < 2 
Tigecycline 8 tet (X4) 8 < 0.25 
Gentamicin 2 aph(6)-Id, aadA1, aadA2, 
ant(2 ′ ’)-Ia, aph(3 ′ ’)-Ib 
< 0.5 < 0.5 
Chloramphenicol > 128 cml 16 < 8 
Colistin < 1 – < 1 < 1 
NOTE: MICs above clinical breakpoints for Enterobacterales have been marked in bold ( https://www.eucast.org/clinical _ 
breakpoints/ ). 




























































igecycline resistance along with tetracycline, sulfamethoxazole, 
hloramphenicol and azithromycin resistance was transferred to 
reen fluorescent protein (GFP)-encoding E. coli strain CV601-GFP 
ia conjugation carried out according to the previously described 
ethod [13] . Transconjugants were obtained with a conjugation 
requency of 2 × 10 –5 transconjugants per recipient cell using 
igecycline (2 μg/mL), kanamycin (50 μg/mL) and rifampicin 
50 μg/mL) for selection. Two transconjugants from the selec- 
ive plates were picked and antimicrobial susceptibility using 
UVSEC Sensititre® plates was performed. Both of the transcon- 
ugants showed an identical resistance profile, being resistant to 
igecycline, tetracycline, sulfamethoxazole, chloramphenicol and 
zithromycin ( Table 1 ), further suggesting the possible presence of 
et (X4)-carrying plasmid pG3X16-2-3 ( Fig. 1 ). 
Moreover, isolate 2-326 carried three other plasmids similar to: 
i) IncFII plasmid pTHO-003-1 from E. coli isolated from human 
putum in Japan (accession no. AP022526.1 ) with > 86% sequence 
overage and 98% nucleotide identity; (ii) IncI1-I(Gamma) plasmid 
ST35-95663.1B from Salmonella enterica serovar Typhimurium iso- 
ated from a bird in Canada (accession no. NZ_CP051282 ) with 
 96% sequence coverage and > 99.6% sequence identity; and (iii) 
ncX4 plasmid pMNCRE44_4 from E. coli causing human sepsis in 
he USA (accession no. CP010880.1 ) with > 86% sequence coverage 
nd 99.4% identity. 
Norway has very low prevalence of tigecycline resistance in 
linical E. coli isolates [14] . Recently, Pan et al. described that Tet(X) 
nzymes have been detected in 23 countries across five conti- 
ents [3] . Detection of the plasmid-mediated tet (X4) gene in Nor- 
ay suggests the ongoing global spread of this tigecycline resis- 
ance mechanism. Our study thus highlights the need for surveil- 
ance of resistance against last-resort antibiotics, especially in a 
ow-prevalence setting such as Norway, in order to mitigate further 
pread of such resistance factors. It also highlights the importance 
f sewage-based surveillance for understanding the prevalence of 
ntibiotic resistance in the population. 
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